KUALA LUMPUR: Nearly 90% of private healthcare facilities and community pharmacies have begun displaying medicine prices since the Medicine Price Display Initiative was rolled out in May last year, according to the Health Ministry.
In a parliamentary written reply dated Monday (Nov 16), the ministry said monitoring of 5,986 premises between May 2025 and September 2026 showed that 5,332 facilities, or 89.1%, had started displaying prices, while 649 premises (10.8%) had yet to comply.
Of the total premises inspected, 3,905 (65.2%) achieved a satisfactory level of display. Community pharmacies recorded the highest satisfactory compliance rate at 73.1%, followed by private hospitals (61.4%), private medical clinics (57.2%), and dental clinics (43.6%).
The figures were provided in response to Tan Kar Hing (PH-Gopeng), who asked for the latest compliance rates and findings on how the policy has affected price transparency, healthy competition, and medicine costs for patients.
Introduced on May 1, 2025, to help consumers compare prices and make informed purchasing decisions, the initiative hit a legal hurdle in July that year when several medical and dental practitioners' associations filed for a judicial review.
"Following this, on May 21, 2026, the Kuala Lumpur High Court granted a stay on the full enforcement of the order. This decision has implications for the full enforcement of the Medicine Price Display Initiative," the ministry said.
Despite the court stay, the ministry said it will continue educational, advocacy, and monitoring efforts to encourage compliance among private healthcare providers.
It added that public feedback remains strongly positive, citing a survey in which 90% of consumers agreed that price displays improve transparency, ease price comparisons, and promote healthier competition among providers.
To further evaluate the policy's impact on consumer behaviour and identify implementation challenges, the ministry will launch a study at the end of this year in collaboration with the National Institutes of Health and the Pharmacy Services Programme, with findings expected by late 2028.
